Application of physiologically active substances isolated from natural resources to pharmacological studies

Japanese Journal of Pharmacology

Volumn 73, Issue 4, 1997, Pages 263-289

  Ohizumi, Yasushi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Excitation contraction coupling; Ion channel; Pharmacological tool; Physiologically active substance; Protein phosphorylation

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATASE (CALCIUM); APAMIN; BROMOEUDISTOMIN; CALCISEPTINE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CONOTOXIN; DENDROTOXIN; GABAPENTIN; GINGEROL; GONIODOMIN A; ION CHANNEL; MACROLIDE; MYCALOLIDE B; MYOSIN; NATURAL PRODUCT; OKADAIC ACID; PEPTIDE; POLYPEPTIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL AFFECTING AGENT; PROTEIN KINASE INHIBITOR; PUREALIN; RYANODINE; RYANODINE RECEPTOR; SODIUM CHANNEL; SODIUM CHANNEL AFFECTING AGENT; STAUROSPORINE; TACROLIMUS; THAPSIGARGIN; TOXIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; XESTOQUINONE;

ACTIN MYOSIN INTERACTION; DRUG STRUCTURE; EXCITATION CONTRACTION COUPLING; HUMAN; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW;

EID: 0030954604     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.73.263     Document Type: Review

References (142)

1. Catterall WA: Molecular properties of voltage-sensitive sodium channels. Annu Rev Biochem 55, 953-985 (1986)
2. 2+ release channel. J Biol Chem 268, 19785-19790 (1993)
3. Norbury C and Nurse P: Animal cell cycles and their control. Annu Rev Biochem 61, 441-470 (1992)
4. Noda M, Suzuki H, Numa S and Stuhmer W: A single point mutation confers tetrodotoxin and saxitoxin insensitivity on the sodium channel II. FEBS Lett 259, 213-216 (1989)
5. Terlau H, Heinemann SH, Stuhmer W, Pusch M, Conti F, Imoto K and Numa S: Mapping the site of block by tetrodotoxin and saxitoxin on sodium channel II. FEBS Lett 293, 93-96 (1991)
6. Backx PH, Yue DT, Lawrence JH, Marban E and Tomaselli GH: Molecular localization of an ion-binding site within the pore of mammalian sodium channels. Science 257, 248-251 (1992)
7. Murata M, Legrand AM Ishibashi Y, Fukui M and Yasumoto T: Structures of ciguatoxin and its congener. J Am Chem Soc 112, 4380-4386 (1990)
8. Benoit E, Legrand AM and Dubois JM: Mechanism of action of ketamine in the current and voltage clamped myelinated nerve fibre of the frog. Toxicon 24, 357-364 (1986)
9. Ohizumi Y, Shibata S and Tachibana K: Mode of excitatory and inhibitory actions of ciguatoxin in the guinea pig vas deferens. J Pharmacol Exp Ther 217, 475-480 (1981)
10. Ohizumi Y, Ishida Y and Shibata S: Mode of the ciguatoxin-induced supersensitivity in the guinea pig vas deferens. J Pharmacol Exp Ther 221, 748-752 (1982)
11. Lewis R J and Endean R: Mode of action of ciguatoxin from the Spanish mackerel, Scomberomorus commersoni, on the guinea pig ileum and vas deferens. J Pharmacol Exp Ther 228, 756-760 (1984)
12. Seino A, Kobayashi M, Momose K, Yasumoto T and Ohizumi Y: The mode of inotropic action of ciguatoxin of guinea pig cardiac muscle. Br J Pharmacol 95, 876-882 (1988)
13. Oleivera BM, Gray WR Zeikus, Mclntosh R, Varga J, Rivier J, Santos V and Cruz LJ: Peptide neurotoxins from fish-hunting cone snail. Science 230, 1338-1343 (1985)
14. Endean R, Parish G and Gyr P: Pharmacology of the venom of Conus geographus. Toxicon 12, 131-138 (1974)
15. Kobayashi J, Nakamura H, Hirata Y and Ohizumi Y: Effect of venoms from Conidae on skeletal, cardiac and smooth muscles. Toxicon 20, 823-830 (1982)
16. Nakamura H, Kobayashi J, Ohizumi Y and Hirata Y: The occurrence of arachidonic acid in the venom duct of the marine snail Conus textile. Experientia 38, 897 (1982)
17. Sato S, Nakamura H, Ohizumi Y, Kobayashi J and Hirata Y: The amino acid sequences of homologous hydroxyproline-containing myotoxins from the marine snail Conus geograhus venom. FEBS Lett 155, 277-280 (1983)
18. Ohizumi Y, Minoshima S, Takahashi M, Kajiwara A, Nakamura H and Kobayashi J: Geographutoxin II, a novel peptide inhibitor of Na channels of skeletal muscle and autonomic nerves. J Pharmacol Exp Ther 239, 243-248 (1986)
19. Kobayashi M, Wu H, Yoshii M, Narahashi T, Nakamura H, Kobayashi J and Ohizumi Y: Preferential block of skeletal muscle sodium channels by geographutoxin II, a new peptide toxin from Conus geographus. Pflugers Arch 407, 241-243 (1986)
20. Gonoi T, Ohizumi Y, Nakamura H, Kobayashi J and Catterall WA: The Conus toxin geographutoxin II distinguishes two functional sodium channel subtypes in rat muscle cells developing in vitro. J Neurosci 7, 1728-1731 (1987)
21. Gonoi T, Hagiwara Y, Kobayashi J, Nakamura H and Ohizumi Y: Geographutoxin-sensitive and insensitive sodium currents in mouse skeletal muscle developing in situ. J Physiol (Lond) 414, 159-177 (1989)
22. Ohizumi Y, Nakamura H and Kobayashi J: Presynaptic inhibitory effect of geographutoxin II, a new peptide toxin from Conus geographus venom in the guinea pig vas deferens. Eur J Pharmacol 120, 245-248 (1986)
23. Hong SJ and Chang CC: Use of geographutoxin II (μ-conotoxin) for the study of neuromuscular transmission in mice. Br J Pharmacol 97, 934-940 (1989)
24. 3H]saxitoxin binding to skeletal muscle sodium channels by geographutoxin II, a polypeptide channel blocker. J Biol Chem 261, 6149-6152 (1986)
25. 3H]saxitoxin and μ-conotoxins. Proc Natl Acad Sci USA 83, 5321-5325 (1986)
26. Sato K, Ishida Y, Wakamatsu K, Kato R, Honda H, Ohizumi Y, Nakamura H, Ohya M, Lancelin J, Kohda D and Inagaki F: Active site of μ-conotoxins G III A, a peptide blocker of muscle sokium channels. J Biol Chem 266, 16989-16991 (1991)
27. Kobayashi J, Nakamura H, Hirata Y and Ohizumi Y: Isolation of a cardiotonic glycoprotein, striatoxin, from the venom of the marine snail Conus striatus. Biochem Biophys Res Commun 105, 1389-1395 (1982)
28. Ohizumi Y, Kobayashi M, Muroyama A, Nakamura H and Kobayashi J: The mechanism of the inotropic action of striatoxin, a novel polipeptide toxin from a marine snail, in isolated cardiac muscle. Br J Pharmacol 95, 867-875 (1988)
29. Kobayashi J, Nakamura H and Ohizumi Y: Biphasic mechanical responses of the guinia-pig isolated ileum to the venom of the marine snail Conus striatus. Br J Pharmacol 73, 583-585 (1981)
30. Gonoi T, Ohizumi Y, Kobayashi J, Nakamura H and Catterall WA: Actions of a polypeptide toxin from the marine snail Conus striatus on voltage-sensitive sodium channels. Mol Pharmacol 32, 691-698 (1987)
31. Benishin CC, Sorensen RG, Brown WE, Krueger BK and Blaustein MP: Four polypeptide components of green mamba venom selectively block certain potassium channels in rat brain synaptosomes. Mol Pharmacol 34, 152-159 (1988)
32. +-channel protein identified by its binding properties for dendrotoxin I. Proc Natl Acad Sci USA 85, 4919-4923 (1988)
33. + channels. Biochem J 257, 899-903 (1989)
34. + channel activity that is stimulated by both cAMP-dependent and endogenous phosphorylations. Biochemistry 28, 6455-6460 (1989)
35. Taylor JW, Bidard J-N and Lazdunski M: The characterization of high-affinity binding sites in rat brain for the mast cell-degranulation peptide from bee venom using the purified monoiodinated peptide. J Biol Chem 259, 13957-13967 (1984)
36. Cherubini E, Ari YB, Gho M, Bidard JN and Lazdunski M: Long-term potentiation of synaptic transmission in the hippocampus induced by a bee venom peptide. Nature 328, 70-77 (1987)
37. Garcia-Calvo M, Leonard RJ, Novick J, Stevens SP, Schmalhofer W, Kaczorowski J and Garcia ML: Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels. J Biol Chem 25, 18866-18874 (1993)
38. Gimenez-Gallego G, Navia MA, Reuben JP, Katz GM, Kaczotowski GJ and Garcia MI: Purification, seguence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels. Proc Natl Acad Sci USA 85, 3329-3333 (1988)
39. Stuhmer W, Ruppersberg JP, Schroter KH, Sakmann B, Stocker M, Giese KP and Perschke A: Molecular basis of functional diversity of voltage-gated potassium channels in mammalian brain. EMBO J 8, 3235-3244 (1989)
40. Price M, Lee SC and Deutsch C: Charybdotoxin inhibits proliferation and interleukin 2 production in human peripheral blood lymphocytes. Proc Natl Acad Sci USA 86, 10171-10175 (1989)
41. + channels. Effects of channel gating, voltage, and ionic strength. J Gen Physiol 91, 317 (1988)
42. Swanson R, Marshall J, Smith JS, Williams JB, Boyle MB, Folander K, Luneau CJ, Antanavage J, Olive C, Buhrow SA, Bennett C, Stein RB and Kaczmarek LK: Cloning and expression of cDNA and genomic clones encoding three delayed rectifier potassium channels in rat brain. Neuron 4, 929-939 (1990)
43. Hugues M, Duval D, Kitabgi P, Lazdunski M and Vincent JP: Preparation of a pure monoiodo derivative of the bee venom neurotoxin apamin and its binding properties to rat brain synaptosomes. J Biol Chem 257, 2762-2769 (1982)
44. + channel in primary neuronal cultures. J Biol Chem 259, 1491-1495 (1984)
45. Cook NS and Haylett DG: Effects of apamin, quinine and neuromuscular blockers on calcium-activated potassium channels in guinea pig hepatocytes. J Physiol (Lond) 358, 373-394 (1985)
46. Chicchi GG, Gimenez-Gallego G, Ber E, Garcia ML, Winquist R and Cascieri MA: Purification and characterization of a unique, potent inhibitor of apamin binding from Leiurus quinquestriatus hebraeus venom. J Biol Chem 263, 10192-10197 (1988)
47. + channels. J Biol Chem 265, 4753-4759 (1990)
48. Galvez A, Gimenez-Gallego G, Reuben JP, Roy-Contancin L, Feigenbaum P, Kaczorowki GJ and Garcia ML: Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem 265, 11083-11090 (1990)
49. + channel. Biophys J 63, 583-590 (1992)
50. + channels characterized from Androctonus mauretanicus mauretanicus venom. J Biol Chem 267, 1640-1647 (1992)
51. Knaus HG, McManus OB, Lee SH, Schmalhofer WA, Garciacalvo M, Helms LMH, Sanchez M, Gian-Giacomo K, Reuben JP, Smith AB, Kaczorowski GJ and Garcia ML: Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels Biochemistry 33, 5819-5828 (1994)
52. ca channel opener, in vascular smooth muscle. Br J Pharmacol 113, 1538-1547 (1994)
53. McManus OB, Harris GH, Giangiacomo KM, Feigenbaum P, Reuben JP, Addy ME, Burka JF, Kaczorowski GJ and Garcia ML: An activator of calcium-dependent potassium channels isolated from a medicinal herb. Biochemistry 32, 6128-6133 (1993)
54. Singh SB, Goetz MA, Zink DL, Dombrowski AW, Polishook JD, Garcia ML, Schmalhofer W, McManus OB and Kaczorowski GJ: Maxikdiol a novel dihydroxy isoprimane as an agonist of maxi-K channels J Chem Soc Perkin Trans 1, 3349-3352 (1994)
55. 2+ channels and their possible counterparts in mammalian CNS neurons. Neuropharmacology 32, 1075-1088 (1993)
56. 2+ channel diversity. Annu Rev Neurosci 17, 399-418 (1994)
57. deWeille JR, Schweitz H, Maes P, Tartar A and Lazdunski M: Calciseptine, a peptide isolated from black mamba venom, is a specific blocker of the L-type calcium channel. Proc Natl Acad Sci USA 88, 2437-2440 (1991)
58. McCleskey IW, Fox AP, Feldman D, Cruz LJ, Olivera BM and Tsien RW: Omega-conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle. Proc Natl Acad Sci USA 84, 4327-4331 (1987)
59. Kasai H and Aosaki T: Divalent cation dependent inactivation of the high-voltage-activated Ca-channel current in chick sensory neurons. Pflugers Arch 411, 695-697 (1988)
60. Plumme MR, Logothetis DE and Hess P: Elementary properties and pharmacological sensitivities of calcium channels in mammalian peripheral neurons. Neuron 2, 1453 (1988)
61. Sher E, Pandiella A and Clementi F: Omega-conotoxin binding and effects on calcium channel function in human neuroblastoma and rat pheochromocytoma cell lines. FFBS Lett 235, 178-182 (1988)
62. Matteson DR and Armstrong CM: Properties of two types of calcium channels in clonal pituitary cells. J Gen Physiol 87, 161-182 (1986)
63. Swandulla D and Armstrong CM: Fast-deactivating calcium channels in chick sensory neurons. J Gen Physiol 92, 197-218 (1988)
64. Carbone E, Sher E and Clementi F: Ca currents in human neuroblastoma IMR32 cells: kinetics, permeability and pharmacology. Pflugers Arch 416, 170-179 (1990)
65. 2+ channel complex purified from brain. Science 261, 486-489 (1993)
66. McEnery MW, Snowman AM, Sharp AH, Adams ME and Snyder SH: Purified ω-conotoxin GVIA receptor of rat brain resembles a dihydropyridine-sensitive L-type calcium channel. Proc Natl Acad Sci USA 88, 11095 (1995)
67. Williams ME, Brust PF, Feldman DH, Patthi S, Simerson S, Maroufi A, McCue AF, Velicelebi G, Ellis SB and Harpold MM: Structure and functional expression of an omega-conotoxin-sensitive human N-type calcium channel. Science 257, 389-395 (1992)
68. 2+ channels. Neuron 9, 69-77 (1992)
69. Mintz IM, Venema VJ, Swiderk KM, Lee TD, Bean BP and Adams ME: P-type calcium channels blocked by the spider toxin ω-Aga-IVA. Nature 355, 827-829 (1992)
70. Murata M, Naoki H, Iwashita T, Matsunaga S, Sasaki M, Yokoyama A and Yasumoto T: Structure of maitotoxin. J Am Chem Soc 115, 2060 (1993)
71. 2+ channel activator candidate. J Biol Chem 257, 7287-7289 (1982)
72. 2+ channel activating function of maitotoxin, the most potent marine toxin known, in clonal rat pheochromocytoma cells. J Biol Chem 258, 10944-10949 (1983)
73. Ohizumi Y and Yasumoto T: Contraction and increase in tissue calcium content induced by maitotoxin, the most potent known marine toxin, in intestinal smooth muscle. Br J Pharmacol 79, 3-5 (1983)
74. Ohizumi Y, Kajiwara A and Yasumoto T: Excitatory effect of the most potent marine toxin, maitotoxin, on the guinea pig vas deferens. J Pharmacol Exp Ther 227, 199-204 (1983)
75. Ohizumi Y and Yasumoto T: Contractile response of the rabbit aorta to maitotoxin, the most potent marine toxin. J Physiol (Lond) 337, 711-721 (1983)
76. 2+ movements in guinea pig and rat cardiac muscles. Br J Pharmacol 86, 385-391 (1985)
77. Kobayashi M, Miyakoda G, Nakamura T and Ohizumi Y: Ca-dependent arrhythmogenic effects of maitotoxin, the most potent marine toxin known, on isolated rat cardiac muscle cells. Br J Pharmacol 111, 121-123 (1985)
78. Kobayashi M, Kondo S, Yasumoto T and Ohizumi Y: Cardiotoxic effects of maitotoxin, a principal toxin of seafood poisoning, on guinea pig and rat cardiac muscle. J Phamacol Exp 238, 1077-1083 (1986)
79. Kobayashi M, Goshima K, Ochi R and Ohizumi Y: Arrhymogenic action of maitotoxin in guinea pig and rat cardiac muscle. Eur J Pharmacol 142, 1-8 (1987)
80. Schettini G, Koike K, Login IS, Judo AM, Cronin MJ, Yasumoto T and Macleod RM: Maitotoxin stimulates hormonal release and calcium flux in rat anterior pituitary cells in vitro. Am J Physiol 247, E520 (1984)
81. Miyamoto T, Ohizumi Y, Washio H and Yasumoto T: Potent excitatory effect of maitotoxin on Ca channels in the insect skeletal muscle. Pflugers Arch 400, 439-441 (1984)
82. 2+-dependent aggregation of rabbit platelets induced by maitotoxin, a potent marine toxin, isolated from a dinoflagellate. Br J Pharmacol 109, 29-36 (1993)
83. Kobayashi M, Ochi R and Ohizumi Y: Maitotoxin-activated single calcium channels in guinea pig cardiac cells. Br J Pharmacol 92, 665-671 (1987)
84. Gusovsky F and Daly W: Maitotoxin: a unique pharmacological tool for research on calcium-dependent mechanisms. Biochem Pharmacol 39, 1633-1639 (1990)
85. Nakamura H, Asari T, Murai A, Kan Y, Kondo T, Yoshida K and Ohizumi Y: Zooxanthellatoxin-A, a potent vasoconstrictive 62-membered lactone from a symbiotic dinoflagellate. J Am Chem Soc 117, 550-551 (1995)
86. 2+-dependent manner by zooxanthellatoxin-A, a novel polyol. Br J Pharmacol 115, 433-440 (1995)
87. Rho M-C, Nakahata N, Nakamura H, Murai A and Ohizumi Y: Tyrphostin 23 selectively blocks phosphorylation of p42 but not p38 mitogen-activated protein kinase by zooxanthellatoxin. Eur J Pharmacol 319, 375-378 (1997)
88. 2+ release channels with ryanodine in junctional terminal cisternae of sarcoplasmic reticulum of fast skeletal muscle. Proc Natl Acad Sci USA 82, 7256 (1985)
89. 2+-permeable pore of the calcium release channel. J Biol Chem 262, 16636 (1987)
90. Inui M, Saito A and Fleischer S: Purification of the ryanodine receptor and identity with feet structures of junctional terminal cisternae of sarcoplasmic reticulum from fast skeletal muscle. J Biol Chem 262, 1740 (1987)
91. Lai FA, Erickson HP, Rousseau E, Lui Q-Y and Meissner G: Purification and reconstitution of the calcium release channel from skeletal muscle. Nature 331, 315 (1989)
92. Smith S, Imagawa T, Ma J, Fill M, Campbell KP and Coronado R: Purified ryanodine receptor from rabbit skeletal muscle is the calcium-release channel of sarcoplasmic reticulum. J Gen Physiol 92, 1 (1988)
93. Takeshima H, Nishimura S, Matsumoto T, Ishida H, Kangawa K, Minamino N, Matsuo H, Ueda M, Hanaoka M, Hirose T and Numa S: Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 339, 439-445 (1989)
94. 2+ release channel. J Biol Chem 268, 19785-19790 (1993)
95. Nakamura Y, Kobayashi J, Gilmore J, Mascal M, Rinehart KL Jr, Nakamura H and Ohizumi Y: Bromo-eudistomin D, a novel inducer of calcium release from fragmented sarcoplasmic reticulum that causes contractions of skinned muscle fibers. J Biol Chem 261, 4139-4142 (1986)
96. Kobayashi J, Ishibashi M, Nagai U and Ohizumi Y: 9-Methyl-7-bromoeudistmin D, a potent inducer of calcium release from sarcoplasmic reticulum of skeletal muscle. Experientia 45, 782-783 (1989)
97. ++ release channels of sarcoplasmic reticulum. J Pharmacol Exp Ther 256, 861-867 (1991)
98. 2+ releaser in skeletal muscle sarcoplasmic reticulum. Eur J Pharmacol (Mol Pharmacol) 288, 285-293 (1995)
99. + current and contractile system in smooth muscles. Am J Physiol 271, 772-782 (1996)
100. 2+ release in skeletal muscle sarcoplasmic reticulum. Br J Pharmacol 114, 941-948 (1995)
101. 3H]methyl-7-bromoeudistomin D to the caffeine-binding site of skeletal muscle sarcoplasmic reticulum. J Biol Chem 268, 18622-18625 (1993)
102. 3H]9-methyl-7-bromoeudistomin D in bovine aortic smooth muscle microsomes. J Pharm Pharmacol 46, 771-773 (1994)
103. 2+ releaser, binds to caffeine-binding sites distinct from the ryanodine receptors in brain microsomes. FEBS Lett 373, 250-254 (1995)
104. 2+ releaser in rabbits. J Pharm Pharmacol 46, 774-776 (1994)
105. 2+ releaser, in liver microsomes is distinct from that in skeletal sarcoplasmic reticulum. Biol Chem Hoppe Seyler 375, 183-187 (1994)
106. 2+ release properties in sarcoplasmic reticulum. Br J Pharmacol 113, 233-239 (1994)
107. 2+ releaser in sarcoplasmic reticulum. Eur J Pharmacol 268, R1-R2 (1994)
108. ++ releasing, agent in skeletal sarcoplasmic reticulum. J Pharmacol Exp Ther 273, 934-939 (1995)
109. 2+ release induced by myotoxin α in skeletal muscle sarcoplasmic reticulum. Can J Physiol Pharmacol 73, 1181-1185 (1995)
110. Nikai T, Suzuki J, Komori Y, Ohkura M, Ohizumi Y and Sugihara H: Primary structure of the lectin from the venom of Bitis arietans (Puff-adder). Biol Pharm Bull 18, 1620-1622 (1995)
111. ++ release induced by puff adder lectin, a novel lectin from the snake Bitis arietans, in sarcoplasmic reticulum. J Pharmacol Exp Ther 277, 1043-1048 (1996)
112. 2+-release channel of skeletal and cardiac muscle. Proc Natl Acad Sci USA 89, 12185-12189 (1992)
113. Mack MM, Molinski TF, Buck ED and Pessah IN: Novel modulators of skeletal muscle FKBP 12/calcium channel complex from Ianthella basta. J Biol Chem 269, 23236-23249 (1994)
114. Timerman AP, Ogunbumni E, Freund E, Wiekerrecht G, Marks AR and Fleischer S: The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein. Dissociation and reconstitution of FKBP-12 to the calcium release channel of skeletal muscle sarcoplasmic reticulum. J Biol Chem 268, 22992-22999 (1993)
115. Mayrleintner M, Timerman AP, Wiederrecht L and Fleischer S: The calcium release channel of sarcoplasmic reticulum is modulated by FK-506 binding protein: effect of FKBP-12 on single channel activity of the skeletal muscle ryanodine receptor. Cell Calcium 15, 99-108 (1994)
116. 1, a 60-membered macrolide from skeletal muscle sarcoplasmic reticulum. Biochim Biophys Acta 1294, 177-182 (1996)
117. 2+-ATPase. Proc Natl Acad Sci USA 87, 2466-2470 (1990)
118. Takemura H, Hughes AR, Thastrup O and Putney IW: Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. J Biol Chem 264, 12266-12271 (1989)
119. 2+ pump. J Biol Chem 267, 12545-12551 (1992)
120. Shoji N, Iwasa A, Takemoto T, Ishida Y and Ohizumi Y: Cardiotonic principles of ginger (Zingiber officinale Roscoe). J Pharm Sci 71, 1174-1175 (1982)
121. ++-pumping adenosine triphosphatase of sarcoplasmic reticulum, in guinea pig atrial muscle. J Pharmacol Exp Ther 246, 667-673 (1988)
122. 2+-pumping ATPase in skeletal and cardiac sarcoplasmic reticulum. Biochim Biophys Acta 903, 96-102 (1987)
123. Nakamura H, Wu H, Kobayashi J, Nakamura Y, Ohizumi Y and Hirata Y: Purealin, a novel enzyme activator from the Okinawan marine sponge Psammaplysilla purea. Tetrahedron Lett 26, 4517-4520 (1985)
124. Nakamura Y, Kobayashi M, Nakamura H, Wu H, Kobayashi J and Ohizumi Y: Purealin, a novel activator of skeletal muscle actomyosin ATPase and myosin EDTA-ATPase that enhanced the superprecipitation of actomyosin. Eur J Biochem 167, 1-6 (1987)
125. Takito J, Nakamura H, Kobayashi J and Ohizumi Y: Enhancement of the actin-activated ATPase activity of myosin from canine cardiac ventricle by purealin. Biochim Biophys Acta 912, 404-407 (1987)
126. Takito J, Nakamura H, Kobayashi J, Ohizumi Y, Ebisawa K and Nonomura Y: Purealin, a novel stabilizer of smooth muscle myosin filaments that modulates ATPase activity of dephosphorylated myosin. J Biol Chem 261, 13861-13865 (1986)
127. Takito J, Ohizumi Y, Nakamura H, Kobayashi J, Ebisawa K and Nonomura Y: The mechanism of inhibition of light chain phosphorylation by purealin in chicken gizzard myosin. Eur J Pharmacol 142, 189-195 (1987)
128. Nakamura H, Kobayashi J, Kobayashi M and Ohizumi Y: Xestoquinone: a novel cardiotonic marine natural product isolated from the Okinawan sea sponge Xestospongia sapra. Chem Lett 713-716 (1985)
129. Kobayashi M, Nakamura H, Kobayashi J and Ohizumi Y: Mechanism of inotropic action of xestoquinone, a novel cardiotonic agent isolated from a sea sponge. J Pharmacol Exp Ther 257, 82-89 (1991)
130. Kobayashi M, Muroyama A, Nakamura H, Kobayashi J and Ohizumi Y: Xestoquinone, a novel cardiotonic agent activates actomyosin ATPase to enhance contractility of skinned cardiac or skeletal muscle fibers. J Pharmacol Exp Ther 257, 90-94 (1991)
131. 2. Biochemistry 34, 12570-12575 (1995)
132. Murakami M, Makabe K, Yamaguchi S, Konosu S and Walchli R: Goniodomin A, a novel polyether macrolide from the dinoflaggellate Goniodoma pseudogoniaulax. Tetrahedron Lett 29, 1149 (1988)
133. Furukawa K-I, Sakai K, Watanabe S, Maruyama K, Murakami M, Yamaguchi K and Ohizumi Y: Goniodomin A induces modulation of actomyosin ATPase activity mediated through conformational change of actin. J Biol Chem 268, 26026-26031 (1993)
134. Fusetani N, Yasumuro K, Matsunaga S and Hashimoto K: Bioactive marine metabolites. Part 28. Mycalolides A-C, hybrid macrolides of ulapualides and halichondramide, from a sponge of the genus Mycale. Tetrahedron Lett 30, 2809 (1989)
135. Hori M, Saito S, Shin YZ, Ozaki H, Fusetani N and Karaki H: Mycalolide-B, a novel and specific inhibitor of actomyosin ATPase isolated from marine sponge. FEBS Lett 322, 151-154 (1993)
136. Saito S, Watanabe S, Ozaki H, Fusetani N and Karaki H: Mycalolide B, a novel actin depolymerizing agent. J Biol Chem 269, 29710-29714 (1994)
137. Wilkinson SE and Halam TJ: Protein kinase C: is its pivotal role in cellular activation overstated? Trends Pharmacol Sci 51, 53 (1993)
138. Akiyama T and Ogawara R: Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol 201, 362-370 (1991)
139. Raynor RL, Zheng B and Kuo JF: Membrane interaction of amphiphilic polypeptide mastoparan, melittin, polymyxin B, and cardiotoxin. J Biol Chem 266, 2753-2758 (1991)
140. Mackintosh C and Klumpp S: Tautomycin from the bacterium Streptomyces verticillatus. Another potent and specific inhibitor of protein phosphatases 1 and 2A. FEBS Lett 277, 137-140 (1990)
141. Carmichael WW: The toxins of cyanobacteria. Sci Am 270, 78-86 (1994)
142. Liu J: FK506 and cyclosporin: molecular probes for studying intracellular signal transduction. Trends Pharmacol Sci 14, 182-188 (1993)